Vilin Bio Med Ltd
Incorporated in 2005, Vilin Bio Med Limited is engaged in manufacturing pharmaceutical products.[1]
- Market Cap ₹ 29.9 Cr.
- Current Price ₹ 21.4
- High / Low ₹ 30.4 / 18.1
- Stock P/E 20.5
- Book Value ₹ 16.8
- Dividend Yield 0.00 %
- ROCE 17.2 %
- ROE 13.8 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -25.9%
- Company has a low return on equity of 5.90% over last 3 years.
- Company has high debtors of 293 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|
| 16.62 | 11.54 | 11.21 | 12.31 | 15.86 | |
| 15.71 | 10.68 | 10.44 | 9.73 | 13.00 | |
| Operating Profit | 0.91 | 0.86 | 0.77 | 2.58 | 2.86 |
| OPM % | 5.48% | 7.45% | 6.87% | 20.96% | 18.03% |
| 0.01 | 0.00 | 0.00 | 0.02 | 0.13 | |
| Interest | 0.41 | 0.44 | 0.51 | 0.65 | 0.71 |
| Depreciation | 0.31 | 0.26 | 0.22 | 0.17 | 0.16 |
| Profit before tax | 0.20 | 0.16 | 0.04 | 1.78 | 2.12 |
| Tax % | 20.00% | 25.00% | 25.00% | 30.34% | |
| 0.16 | 0.12 | 0.03 | 1.25 | 1.46 | |
| EPS in Rs | 0.48 | 0.36 | 0.09 | 1.26 | 1.24 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -10% |
| TTM: | 75% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 98% |
| TTM: | 156% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|
| Equity Capital | 3.30 | 3.30 | 3.30 | 9.95 | 13.95 |
| Reserves | 3.94 | 4.06 | 4.10 | 0.73 | 9.50 |
| 4.53 | 5.52 | 5.30 | 4.93 | 5.52 | |
| 2.24 | 1.01 | 0.86 | 2.07 | 1.97 | |
| Total Liabilities | 14.01 | 13.89 | 13.56 | 17.68 | 30.94 |
| 2.13 | 1.87 | 1.65 | 1.51 | 1.44 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 11.88 | 12.02 | 11.91 | 16.17 | 29.50 | |
| Total Assets | 14.01 | 13.89 | 13.56 | 17.68 | 30.94 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| -1.46 | -1.00 | 0.21 | -1.66 | |
| -0.02 | 0.00 | 0.00 | -0.03 | |
| 1.51 | 0.98 | -0.22 | 1.68 | |
| Net Cash Flow | 0.03 | -0.02 | -0.01 | 0.00 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Debtor Days | 159.66 | 241.96 | 253.64 | 292.65 |
| Inventory Days | 56.13 | 83.17 | 93.82 | 44.74 |
| Days Payable | 49.48 | 33.11 | 26.34 | 60.49 |
| Cash Conversion Cycle | 166.31 | 292.03 | 321.13 | 276.89 |
| Working Capital Days | 210.39 | 346.66 | 360.44 | 333.57 |
| ROCE % | 4.87% | 4.30% | 17.17% |
Business Profile[1] Vilin Bio Med Limited was established in Hyderabad in 2009. Company manufactures pharmaceutical products domestically and sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who provide the channel for sales to customers.